glp-1 news employers Agonists: Managing Employee Health and Employer Costs Here's how weight-loss drugs like

One of the main predictors of whether you are a viable candidate to need Semaglutide GLP-1 injections for weight loss is if you are considered obese, which is indicated by a body mass index of 30 or over

They compared patients who initiated the glucagon-like peptide-1 receptor agonists (GLP-1s) semaglutide, tirzepatide, or liraglutide within one year of a cirrhosis diagnosis with those who underwent metabolic bariatric surgery (MBS) during the same period

Side effects are typically mild and manageable

GLP-1 A Specialty-Tier Drug The financial burden for insured consumers can remain substantial even when coverage is approved